Category: Latest News

  • Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition

    Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition

    Artivion Inc. (NYSE:AORT) said the U.S. Food and Drug Administration has approved the premarket application for the NEXUS Aortic Arch System, a device developed by its partner Endospan Ltd. The regulatory clearance gives Artivion the option to acquire Endospan within a 90-day window. The company has arranged a $150 million delayed-draw term loan to help…

  • AC Immune revises collaboration with Eli Lilly on tau-targeting Alzheimer’s therapy

    AC Immune revises collaboration with Eli Lilly on tau-targeting Alzheimer’s therapy

    AC Immune SA (NASDAQ:ACIU) said it has amended its 2018 licensing and collaboration agreement with Eli Lilly and Company (NYSE:LLY) focused on developing small-molecule tau aggregation inhibitors for Alzheimer’s disease and other neurodegenerative disorders. As part of the revised terms, AC Immune will receive an upfront payment of CHF10 million and an additional milestone payment…

  • TransCode Therapeutics signs financing deal worth up to $20 million

    TransCode Therapeutics signs financing deal worth up to $20 million

    TransCode Therapeutics Inc. (NASDAQ:RNAZ) said it has secured a financing agreement with an institutional healthcare investor that could provide the company with up to $20 million in funding. The arrangement includes up to $6 million in prepaid advances, along with a three-year Standby Equity Purchase Agreement that allows TransCode to sell as much as $14…

  • Intel shares rise after joining Terafab semiconductor initiative

    Intel shares rise after joining Terafab semiconductor initiative

    Intel (NASDAQ:INTC) shares climbed about 2% on Tuesday morning after the company confirmed it has joined the Terafab chip manufacturing initiative alongside SpaceX, xAI and Tesla. The stock moved higher following reports that Intel hosted Elon Musk over the weekend and subsequently announced its participation in the project. In a post on X, Intel said…

  • Planet Labs tests onboard AI object detection on Pelican-4 satellite

    Planet Labs tests onboard AI object detection on Pelican-4 satellite

    Planet Labs PBC (NYSE:PL) said it has successfully carried out AI-powered object detection directly aboard its Pelican-4 satellite, marking a step forward in real-time space-based data analysis. The test, conducted on March 25, involved capturing imagery of an airport located about 500 kilometers above Alice Springs, Australia, and identifying aircraft shortly after the image was…

  • Uber expands AWS infrastructure to boost ride-matching and delivery efficiency

    Uber expands AWS infrastructure to boost ride-matching and delivery efficiency

    Uber Technologies Inc. (NYSE:UBER) said it is increasing its use of Amazon Web Services (AWS) infrastructure to improve the performance of its ride-hailing and delivery platforms. The company is rolling out AWS Graviton4 computing instances to power more of its Trip Serving Zones, the system that processes ride and delivery requests in real time. Trip…

  • Lunai Bioworks unit secures defense collaboration for AI chemical threat platform

    Lunai Bioworks unit secures defense collaboration for AI chemical threat platform

    Lunai Bioworks Inc. (NASDAQ:LNAI) said its subsidiary BioSymetrics has signed a multi-year commercial partnership with a biotechnology company to develop an artificial intelligence–enabled platform focused on assessing chemical threats. Under the collaboration, BioSymetrics will apply its phenotypic screening technology and AI capabilities to detect and categorize neuroactive and neurotoxic compounds. The initiative expands Lunai Bioworks’…

  • Acadia launches powder version of Rett syndrome treatment in the U.S.

    Acadia launches powder version of Rett syndrome treatment in the U.S.

    Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) said its new powder formulation of trofinetide, marketed as DAYBUE STIX, is now available in the United States for the treatment of Rett syndrome. The U.S. Food and Drug Administration approved the formulation in December 2025. DAYBUE STIX is a dye- and preservative-free powder designed to be mixed with water-based liquids…

  • Helport AI deploys AI-driven debt collection platform with Asian finance partner

    Helport AI deploys AI-driven debt collection platform with Asian finance partner

    Helport AI Limited (NASDAQ:HPAI) said it has launched an artificial intelligence–powered debt collection system in collaboration with a consumer finance company in Asia, according to a company statement. The technology firm said its AI labor platform has been integrated into the partner’s financial services operations, with the goal of improving recovery outcomes, enhancing customer interactions…

  • Amentum awarded $425 million CAL FIRE aviation support contract

    Amentum awarded $425 million CAL FIRE aviation support contract

    Amentum (NYSE:AMTM) has secured a $425 million contract from the California Department of Forestry and Fire Protection (CAL FIRE) to deliver aerial firefighting support services. The agreement runs for an initial three-year term and includes two optional extensions that could lengthen the partnership. Under the contract, Amentum will coordinate the training, scheduling and deployment of…